Anastomose portosystémique intrahépatique percutanée

EMC - Radiologie Pub Date : 2005-05-01 DOI:10.1016/j.emcrad.2005.01.002

P. Legmann (Professeur des Universités, praticien hospitalier, chef de service), O. Vignaux (Professeur des Universités, praticien hospitalier), J. Uzan-Augui (Praticien hospitalier), H. Gouya (Chef de clinique-assistant des Hôpitaux), S. Silvera (Chef de clinique-assistant des Hôpitaux), A.-E. Millischer-Bellaiche (Chef de clinique-assistant des Hôpitaux), H. Bahurel-Barrera (Praticien attaché)

{"title":"Anastomose portosystémique intrahépatique percutanée","authors":"P. Legmann (Professeur des Universités, praticien hospitalier, chef de service), O. Vignaux (Professeur des Universités, praticien hospitalier), J. Uzan-Augui (Praticien hospitalier), H. Gouya (Chef de clinique-assistant des Hôpitaux), S. Silvera (Chef de clinique-assistant des Hôpitaux), A.-E. Millischer-Bellaiche (Chef de clinique-assistant des Hôpitaux), H. Bahurel-Barrera (Praticien attaché)","doi":"10.1016/j.emcrad.2005.01.002","DOIUrl":null,"url":null,"abstract":"<div><p>Transjugular intrahepatic porto-systemic shunts (TIPS) have been developed in the 80’s, for the treatment of portal hypertension complications. Their indications include active bleeding from gastro-esophageal varix, and control of refractory cirrhotic ascites, especially in patients awaiting liver transplantation. New indications include hepatic hydrothorax, hepato-renal failure, and the treatment of the Budd-Chiari syndrome. TIPS have been shown to provide better control than endoscopic sclerotherapy, in the prevention of re-bleeding from gastro-esophageal varix and in the treatment of refractory cirrhotic ascites. Complications of TIPS procedures are possible and include encephalopathy, stent occlusion and stenosis. Using Polythetrafluoroethylen covered endoprosthesis (EPTFE) should improve the permeability of the TIPS.</p></div>","PeriodicalId":100447,"journal":{"name":"EMC - Radiologie","volume":"2 2","pages":"Pages 183-196"},"PeriodicalIF":0.0000,"publicationDate":"2005-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.emcrad.2005.01.002","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EMC - Radiologie","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1762418505000038","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Transjugular intrahepatic porto-systemic shunts (TIPS) have been developed in the 80’s, for the treatment of portal hypertension complications. Their indications include active bleeding from gastro-esophageal varix, and control of refractory cirrhotic ascites, especially in patients awaiting liver transplantation. New indications include hepatic hydrothorax, hepato-renal failure, and the treatment of the Budd-Chiari syndrome. TIPS have been shown to provide better control than endoscopic sclerotherapy, in the prevention of re-bleeding from gastro-esophageal varix and in the treatment of refractory cirrhotic ascites. Complications of TIPS procedures are possible and include encephalopathy, stent occlusion and stenosis. Using Polythetrafluoroethylen covered endoprosthesis (EPTFE) should improve the permeability of the TIPS.

查看原文本刊更多论文

经皮肝内口系统吻合

经颈静脉肝内门静脉-全身分流术(TIPS)是在80年代发展起来的，用于治疗门静脉高压并发症。其适应症包括胃食管静脉曲张活动性出血和难治性肝硬化腹水的控制，特别是等待肝移植的患者。新的适应症包括肝性胸水、肝肾衰竭和Budd-Chiari综合征的治疗。TIPS已被证明在预防胃食管静脉曲张再出血和治疗难治性肝硬化腹水方面比内镜硬化疗法提供更好的控制。TIPS手术可能出现并发症，包括脑病、支架闭塞和狭窄。采用聚氟乙烯包覆人工体(EPTFE)可提高TIPS的通透性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

EMC - Radiologie

自引率

0.00%

发文量